Does Re-intubation Increased Risk of Ventilator- Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients?

Authors

  • Nemat Bilan Pediatric Pulmonologist, Pediatric Health Research Centre, Tabriz University of Medical Sciences,Tabriz, Iran.
  • Parinaz Habibi Pediatrician, Pediatric Health Research Centre, Tabriz University of Medical Sciences,Tabriz, Iran.
Abstract:

Introduction:ventilator- associated pneumonia(VAP),as defined by the centers for disease control and prevention (CDC),is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation.re-intubation which occur within 72 hours of planned extubation may effect VAP incidence.the aim of this study was to determine VAP incidence in re-intubated patients in comparision with patients underwent intubation without re-intubation to highlight re-intubation as a risk factor for VAP .Methods and materials: 1230 intubated patients ,admitted to PICU department were enrolled in this cohort observational study consecutively from may 2010 to may 2014.VAP was clinically suggested and confirmed by chest x-ray .patients demographic data,underlying disease,duration of mechanical ventilationlength of picu stayand re-intubations were recorded prospectively. This study was approved by the institute,s ethics committee.Results: 336 intubated patients out of 1230 patients admitted to PICU department developed VAP(27%) with higher incidence in reintubated patients(30% vs 12%).Conclusion: VAP developed in nearly one third of intubated patients in our study.re-intubation was significant risk factor for development of VAP.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

does re-intubation increased risk of ventilator- associated pneumonia (vap) in pediatric intensive care unit patients?

introduction:ventilator- associated pneumonia(vap),as defined by the centers for disease control and prevention (cdc),is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation.re-intubation which occur within 72 hours of planned extubation may effect vap incidence.the aim of this study was to determine vap incidence i...

full text

Does Re-intubation Increased Risk of Ventilator - Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients?

Abstract Introduction Ventilator Associated Pneumonia (VAP), as defined by the Centers for Disease Control and prevention (CDC), is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation. Re-intubation which occur within 72 hours of planned extubation may be effective in VAP incidence. The aim of this study was to det...

full text

Treatment Protocol of Ventilator-Associated Pneumonia based on Microbial Susceptibility in Pediatric Intensive Care Unit, Isfahan, Iran

Background Choosing a unique empiric treatment for ventilator associated pneumonia (VAP) can be challenging. We aimed to determine the antimicrobial susceptibility pattern of Intensive Care Unit (ICU) of the only referral pediatric hospital in Isfahan in order to design the optimal empiric treatment protocol. Materials and Methods: </strong...

full text

Evolution ventilator associated pneumonia (VAP) in our intensive care unit, after pneumonia zero (PZ) program implementation

Introduction The National Survey of Nosocomial Infection Surveillance (ENVIN) is a computerized record of the incidence of nosocomial infection in ICU in Spain. Most international scientific societies have developed their own recommendations to avoid VAP. In our hospital, we have drafted rules for the maintenance of the airway in mechanically ventilated patients following general recommendation...

full text

Methicillin Resistant Staphylococcus Aureus in Ventilator Associated ‎Pneumonia in Toxicological Intensive Care Unit

Background: Methicillin resistant Staphylococus Aureus (MRSA) is a cause of ‎nosocomial infections at intensive care unit (ICU), which imposes a high mortality and ‎morbidity on the health care systems.‎ The objective of this study was to evaluate the role of MRSA in patients with clinically ‎suspected ventilator associated pneumonia (VAP) in toxicological ICU admitted ‎patients.Methods: This ...

full text

The prevalence of Mycoplasma pneumoniae infection in patients with ventilator-associated pneumonia hospitalized in intensive care unit

Background: Ventilator-associated pneumonia (VAP) is a type of hospital acquired pneumonia with the mortality rate between 27% and 76% that develops more than 48–72 h after endotracheal intubation. Possible causes leading to this infection can be Mycoplasma pneumoniae. The objective of this study was to determine the presence of Mycoplasma pneumoniae in bronchoalveolar samples of patients with ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 3  issue 1.1

pages  411- 415

publication date 2015-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023